Name (Synonyms) | Correlation | |
---|---|---|
drug1722 | MenACWY boost Wiki | 1.00 |
drug1848 | Nebulized Sterile Saline Wiki | 1.00 |
drug641 | ChAdOx1 nCoV-19 half boost Wiki | 1.00 |
drug2053 | Paracetamol Wiki | 1.00 |
drug640 | ChAdOx1 nCoV-19 full boost Wiki | 1.00 |
drug1721 | MenACWY Wiki | 1.00 |
drug636 | ChAdOx1 nCoV-19 Wiki | 0.71 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
To evaluate and compare nebulized platelet lysate to placebo control of saline administered via handheld nebulizer 1x daily for eight weeks to determine effect on lung function in patients with post-COVID-19 ARDS syndrome.
Description: Changes in pre and post treatment spirometry measures
Measure: Spirometry-FVC and FEV1/FVC tests Time: 4 weeks; 8 weeksDescription: Changes from pre and post treatment spirometry measures
Measure: Spirometry-FVC and FEV1/FVC tests Time: 3 months, 6 monthsDescription: Changes in distance walked during 6MWD test from pre to post treatment
Measure: 6 Minute Walk Distance test (6MWD) Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: Changes in distance-desaturation product from 6MWD from pre to post treatment
Measure: Distance-desaturation product from 6MWD Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: Changes in San Diego Shortness of Breath Questionnaire (SOBQ) score from pre to post; treatment; scores range from 0-120 with higher scores equaling greater breathing impairment
Measure: San Diego Shortness of Breath Questionnaire (SOBQ) Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: Changes in SF-36 scores from pre to post treatment; 8 subscales 0-100 range where lower scores equal more disability
Measure: Short Form-36 (SF-36) Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: Average SANE score post treatment; scores range from 0-100 where 0=no improvement and 100=100% improvement in breathing condition
Measure: Modified Single Assessment Numeric Evaluation (SANE) Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: changes in medications from pre to post treatment
Measure: Medications Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: Incidence of adverse events after treatment
Measure: Incidence of adverse events Time: 4 weeks; 8 weeks; 3 months; 6 monthsDescription: Incidence of surgical/other treatment interventions after treatment
Measure: Incidence of surgical/other treatment interventions Time: 4 weeks; 8 weeks; 3 months; 6 months